Motion Stimulation Therapy Market Report 2025

The motion stimulation therapy market size has grown strongly in recent years. It will grow from $1.81 billion in 2024 to $1.96 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth during the historic period can be attributed to the rising prevalence of neurodegenerative diseases, increasing awareness of physical rehabilitation, growing demand for non-invasive therapy options, a expanding geriatric population requiring mobility support, and the rising incidence of sports-related injuries.

The motion stimulation therapy market size is expected to see strong growth in the next few years. It will grow to $2.68 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth during the forecast period can be attributed to the rising demand for wearable and portable therapy devices, increasing adoption of telehealth and remote monitoring platforms, growing prevalence of lifestyle-related disorders, heightened demand for personalized and targeted motion therapy solutions, and an increased focus on preventive healthcare driving motion therapy usage. Key trends expected during the forecast period include the development of compact simulation platforms, advancements in haptic feedback technology, innovations in AI-powered simulators, the creation of portable devices for at-home therapy sessions, and the integration of biofeedback systems to enhance therapy effectiveness.

The rising prevalence of musculoskeletal disorders is expected to drive the growth of the motion stimulation therapy market in the coming years. Musculoskeletal disorders are conditions affecting muscles, bones, joints, tendons, and ligaments, leading to pain or restricted movement. This increase is largely attributed to the aging global population, as joint degeneration and reduced bone density naturally occur over time. Motion stimulation therapy aids in treating musculoskeletal disorders by improving mobility and alleviating pain, providing targeted stimulation to affected areas to support faster recovery and better patient outcomes. For example, in January 2024, the Office for Health Improvement and Disparities, a UK-based government department, reported that the prevalence of long-term musculoskeletal (MSK) conditions among people aged 16 and over who self-reported was 18.4% in 2023, up from 17.6% in 2022. As a result, the growing incidence of musculoskeletal disorders is driving the expansion of the motion stimulation therapy market.

Leading companies in the motion stimulation therapy market are developing advanced solutions, such as closed-loop spinal cord stimulators, to enhance real-time pain management and improve patient outcomes. Closed-loop spinal cord stimulators are sophisticated devices that continuously monitor nerve signals and automatically adjust stimulation levels, providing personalized and effective pain relief. For instance, in April 2024, Medtronic plc, an Ireland-based medical technology company, received U.S. Food and Drug Administration (FDA) approval for the Inceptiv closed-loop rechargeable spinal cord stimulator for chronic pain treatment. This device enhances motion stimulation therapy by dynamically adapting to patients’ movements and pain levels, monitoring nerve signals 50 times per second, and adjusting stimulation in real time for consistent, personalized relief during daily activities. Additionally, it is the smallest and thinnest spinal cord stimulator on the market, offering full-body MRI compatibility at both 1.5T and 3T, ensuring greater patient comfort and uninterrupted access to diagnostic imaging.

In February 2023, Confluent Health LLC, a US-based healthcare company, acquired Motion PT Group for an undisclosed sum. Through this acquisition, Confluent Health aims to expand its national reach and enhance patient care by increasing access to advanced management services and innovative musculoskeletal health programs. Motion PT Group is a US-based company specializing in motion stimulation therapy.

Major players in the motion stimulation therapy market are Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Ottobock SE & Co. KGaA, Nevro Corporation, Zynex Medical Inc., BTL Industries Inc., Onward Medical Inc., Enraf-Nonius B.V., Hocoma AG, Tyromotion GmbH, EW Motion Therapy, Ekso Bionics Holdings Inc., Mettler Electronics Corporation, Bioness Inc., Restorative Therapies Inc., ARPwave Therapy, Innovative Neurotronics Inc., St. Jude Medical Inc., Technomed Electronics Co Ltd.

North America was the largest region in the motion simulation therapy market in 2024. The regions covered in motion stimulation therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the motion stimulation therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Motion stimulation therapy is a therapeutic technique that employs controlled movements or mechanical motion to stimulate the body or targeted tissues. Its primary goal is to improve circulation, reduce muscle stiffness, and promote healing by encouraging natural motion and sensory feedback. This therapy is commonly used in rehabilitation to enhance mobility and relieve pain.

The primary types of motion stimulation therapy include functional neuromuscular motion stimulation therapy, peripheral motion stimulation therapy, deep brain motion stimulation therapy, and therapeutic electrical motion stimulation therapy. Functional neuromuscular motion stimulation therapy is a therapeutic approach that uses electrical stimulation to activate muscles and nerves, thereby enhancing muscle function and improving motor control. This therapy finds applications in areas such as diabetes management, pain management, oncology, cardiovascular diseases, infectious diseases, and more, serving end users including hospitals, specialty clinics, and other healthcare facilities.

The motion stimulation therapy market research report is one of a series of new reports that provides motion stimulation therapy market statistics, including motion stimulation therapy industry global market size, regional shares, competitors with a motion stimulation therapy market share, detailed motion stimulation therapy market segments, market trends and opportunities, and any further data you may need to thrive in the motion stimulation therapy industry. This motion stimulation therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The motion stimulation therapy market consists of revenues earned by entities by providing services such as soft tissue motion therapy, limb motion stimulation, subthalamic nucleus stimulation, and pain management stimulation. The market value includes the value of related goods sold by the service provider or included within the service offering. The motion stimulation therapy market also includes sales of spinal cord stimulators, wearable motion therapy devices, vagus nerve stimulators, and implantable pulse generators. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.